This inventor holds 2 USPTO granted patents, plus 1 CIPO patent. Top assignee: Alfa Wassermann, Inc.. Active years: 1999-2005.
Company Filing History:
Years Active: 1999-2005
Title: Innovator Patrizio Ferrari: Advancements in Probiotics and Pharmaceutical Compositions
Introduction
Patrizio Ferrari is a notable inventor based in Bologna, Italy. He has made significant contributions to the fields of probiotics and pharmaceutical compositions, holding a total of 2 patents. His work focuses on improving gastrointestinal health and addressing serious medical conditions.
Latest Patents
Ferrari's latest patents include innovative developments in the use of bifidobacteria. The first patent details biologically pure cultures of two strains, W11 and W11, which are registered with the Belgian Coordinated Collections of Microorganisms (BCCM). These strains are utilized as probiotics in pharmaceutical and alimentary products to enhance gastrointestinal health and prevent intestinal pathologies. The second patent involves the use of rifaximin and pharmaceutical compositions containing it. This invention targets the treatment of diarrheal symptoms associated with cryptosporidiosis, particularly in patients with severe immunodepression, such as those suffering from AIDS or undergoing chemotherapy.
Career Highlights
Patrizio Ferrari is currently associated with Alfa Wassermann, Inc., where he continues to innovate in the field of pharmaceuticals. His work has been instrumental in developing effective treatments that address critical health issues.
Collaborations
Ferrari collaborates with esteemed colleagues, including Lorenzo Morelli and Antonella Ferrieri. Their combined expertise contributes to the advancement of research and development in their respective fields.
Conclusion
Patrizio Ferrari's contributions to probiotics and pharmaceutical compositions highlight his commitment to improving health outcomes. His innovative patents reflect a dedication to addressing significant medical challenges.